Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.
BACKGROUND:Previously we have shown that Ag85B-TB10.4 is a highly efficient vaccine against tuberculosis when delivered in a Th1 inducing adjuvant based on cationic liposomes. Another Th1 inducing adjuvant, which has shown a very promising profile in both preclinical and clinical trials, is IC31. In...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-06-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2691953?pdf=render |
_version_ | 1818386765248987136 |
---|---|
author | Claus Aagaard Truc Thi Kim Thanh Hoang Angelo Izzo Rolf Billeskov JoLynn Troudt Kim Arnett Andrew Keyser Tara Elvang Peter Andersen Jes Dietrich |
author_facet | Claus Aagaard Truc Thi Kim Thanh Hoang Angelo Izzo Rolf Billeskov JoLynn Troudt Kim Arnett Andrew Keyser Tara Elvang Peter Andersen Jes Dietrich |
author_sort | Claus Aagaard |
collection | DOAJ |
description | BACKGROUND:Previously we have shown that Ag85B-TB10.4 is a highly efficient vaccine against tuberculosis when delivered in a Th1 inducing adjuvant based on cationic liposomes. Another Th1 inducing adjuvant, which has shown a very promising profile in both preclinical and clinical trials, is IC31. In this study, we examined the potential of Ag85B-TB10.4 delivered in the adjuvant IC31 for the ability to induce protection against infection with Mycobacterium tuberculosis. In addition, we examined if the antigen dose could influence the phenotype of the induced T cells. METHODS AND FINDINGS:We found that vaccination with the combination of Ag85B-TB10.4 and IC31 resulted in high numbers of polyfunctional CD4 T cells co-expressing IL-2, IFN-gamma and TNF-alpha. This correlated with protection against subsequent challenge with M.tb in the mouse TB model. Importantly, our results also showed that both the vaccine induced T cell response, and the protective efficacy, was highly dependent on the antigen dose. Thus, whereas antigen doses of 5 and 15 microg did not induce significant protection against M.tb, reducing the dose to 0.5 microg selectively increased the number of polyfunctional T cells and induced a strong protection against infection with M.tb. The influence of antigen dose was also observed in the guinea pig model of aerosol infection with M.tb. In this model a 2.5 fold increase in the antigen dose reduced the protection against infection with M.tb to the level observed in non-vaccinated animals. CONCLUSIONS/SIGNIFICANCE:Small changes in the antigen dose can greatly influence the induction of specific T cell subpopulations and the dose is therefore a crucial factor when testing new vaccines. However, the adjuvant IC31 can, with the optimal dose of Ag85B-TB10.4, induce strong protection against Mycobacterium tuberculosis. This vaccine has now entered clinical trials. |
first_indexed | 2024-12-14T03:59:15Z |
format | Article |
id | doaj.art-73337be1b5dd4c63aea3644c43069708 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-14T03:59:15Z |
publishDate | 2009-06-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-73337be1b5dd4c63aea3644c430697082022-12-21T23:18:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-06-0146e593010.1371/journal.pone.0005930Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.Claus AagaardTruc Thi Kim Thanh HoangAngelo IzzoRolf BilleskovJoLynn TroudtKim ArnettAndrew KeyserTara ElvangPeter AndersenJes DietrichBACKGROUND:Previously we have shown that Ag85B-TB10.4 is a highly efficient vaccine against tuberculosis when delivered in a Th1 inducing adjuvant based on cationic liposomes. Another Th1 inducing adjuvant, which has shown a very promising profile in both preclinical and clinical trials, is IC31. In this study, we examined the potential of Ag85B-TB10.4 delivered in the adjuvant IC31 for the ability to induce protection against infection with Mycobacterium tuberculosis. In addition, we examined if the antigen dose could influence the phenotype of the induced T cells. METHODS AND FINDINGS:We found that vaccination with the combination of Ag85B-TB10.4 and IC31 resulted in high numbers of polyfunctional CD4 T cells co-expressing IL-2, IFN-gamma and TNF-alpha. This correlated with protection against subsequent challenge with M.tb in the mouse TB model. Importantly, our results also showed that both the vaccine induced T cell response, and the protective efficacy, was highly dependent on the antigen dose. Thus, whereas antigen doses of 5 and 15 microg did not induce significant protection against M.tb, reducing the dose to 0.5 microg selectively increased the number of polyfunctional T cells and induced a strong protection against infection with M.tb. The influence of antigen dose was also observed in the guinea pig model of aerosol infection with M.tb. In this model a 2.5 fold increase in the antigen dose reduced the protection against infection with M.tb to the level observed in non-vaccinated animals. CONCLUSIONS/SIGNIFICANCE:Small changes in the antigen dose can greatly influence the induction of specific T cell subpopulations and the dose is therefore a crucial factor when testing new vaccines. However, the adjuvant IC31 can, with the optimal dose of Ag85B-TB10.4, induce strong protection against Mycobacterium tuberculosis. This vaccine has now entered clinical trials.http://europepmc.org/articles/PMC2691953?pdf=render |
spellingShingle | Claus Aagaard Truc Thi Kim Thanh Hoang Angelo Izzo Rolf Billeskov JoLynn Troudt Kim Arnett Andrew Keyser Tara Elvang Peter Andersen Jes Dietrich Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. PLoS ONE |
title | Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. |
title_full | Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. |
title_fullStr | Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. |
title_full_unstemmed | Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. |
title_short | Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. |
title_sort | protection and polyfunctional t cells induced by ag85b tb10 4 ic31 against mycobacterium tuberculosis is highly dependent on the antigen dose |
url | http://europepmc.org/articles/PMC2691953?pdf=render |
work_keys_str_mv | AT clausaagaard protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose AT tructhikimthanhhoang protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose AT angeloizzo protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose AT rolfbilleskov protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose AT jolynntroudt protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose AT kimarnett protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose AT andrewkeyser protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose AT taraelvang protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose AT peterandersen protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose AT jesdietrich protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose |